Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of artesunate-amodiaquine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for uncomplicated falciparum malaria in Sierra Leone
ACTRN12618000517279Phase 4Completed
- Sponsor
- Sierra Leone Ministry of Health and Sanitation
- Start
- Mar 2016
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether, lumefantrine, dihydroartemisinin and 1 more in Malaria and malaria (3 arms), sponsored by Sierra Leone Ministry of Health and Sanitation. Primary endpoint: Percent of treatment failures. Started Mar 2016; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrinedihydroartemisinin
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12618000517279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000517279.